Skip to NavigationSkip to content

Europe unaffected by GSK's manufacturing problems

Published on 31/03/05 at 11:35am

Batches of GlaxoSmithKline's diabetes treatment Avandamet and depression treatment Paxil CR have been seized in the US due to continuing concerns about manufacturing problems at the company's Puerto Rico plant.

The EMEA said it agreed with an FDA assessment that no recall of products was required in the foreseeable future, but the European regulator said its inspectors will visit the Puerto Rico plant shortly and will be ready for any implications for EU patients.

GSK maintained that the seized medicines do not pose a risk to patients but said it was working with the FDA to meet its requirements.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches